Combination of a glycomimetic antagonist tp e-selectin and CXCR4, GMI-1359, with an anti-PD-L1 antibody attenuates regulatory T cell infiltration and accelerates time to complete response in the murine CT26 tumor model
November 14, 2016
GlycoMimetics, Inc. and MI Bioresearch Poster for SITC